Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-7 ل  7 نتائج ل ""Phase III as Topic""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens.

  • Authors : Phillips PPJ; MRC Clinical Trials Unit at UCL, London, UK. .; Division of Pulmonary & Critical Care Medicine, University of California, San Francisco, San Francisco, USA. .

Subjects: Bacteriological Techniques* ; Clinical Trials, Phase III as Topic* ; Culture Media*

  • Source: BMC medicine [BMC Med] 2017 Nov 24; Vol. 15 (1), pp. 207. Date of Electronic Publication: 2017 Nov 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
Academic Journal

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).

  • Authors : Dong D; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, No. 95 Zhongguancun East Road, Hai Dian District, Beijing, 100190, People's Republic of China.; Department of Radiation oncology, State Key Laboratory of Oncology in South China

Subjects: Induction Chemotherapy*/Induction Chemotherapy*/Induction Chemotherapy*/statistics & numerical data; Magnetic Resonance Imaging/Magnetic Resonance Imaging/Magnetic Resonance Imaging/*methods ; Nasopharyngeal Carcinoma/Nasopharyngeal Carcinoma/Nasopharyngeal Carcinoma/*diagnosis

  • Source: BMC medicine [BMC Med] 2019 Oct 23; Vol. 17 (1), pp. 190. Date of Electronic Publication: 2019 Oct 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
Academic Journal

Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.

  • Authors : Boutron I; INSERM, UMR 1153, Epidemiology and Biostatistics Research Center (CRESS), Methods Team, Paris, France. .; Faculté de Médecine, Paris Descartes University, Paris, France. .

Subjects: Communication* ; Data Accuracy* ; Perception*

  • Source: BMC medicine [BMC Med] 2019 Jun 04; Vol. 17 (1), pp. 105. Date of Electronic Publication: 2019 Jun 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
Academic Journal

Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

  • Authors : Remon J; Cancer Medicine Department, Gustave Roussy, Villejuif, France.; Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Immunotherapy/Immunotherapy/Immunotherapy/*methods

  • Source: BMC medicine [BMC Med] 2017 Mar 13; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2017 Mar 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
Academic Journal

Phosphodiesterase 4-targeted treatments for autoimmune diseases.

  • Authors : Kumar N; Department of Dermatology, Tufts Medical Center, 800 Washington Street #114, Boston, MA 02111, USA. ; Goldminz AM

Subjects: Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*drug therapy ; Phosphodiesterase 4 Inhibitors/Phosphodiesterase 4 Inhibitors/Phosphodiesterase 4 Inhibitors/*therapeutic use; Chronic Disease/Chronic Disease/Chronic Disease/drug therapy

  • Source: BMC medicine [BMC Med] 2013 Apr 04; Vol. 11, pp. 96. Date of Electronic Publication: 2013 Apr 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
Editorial & Opinion

Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?

  • Authors : Zhu AX; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Benzenesulfonates/Benzenesulfonates/Benzenesulfonates/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy

  • Source: BMC medicine [BMC Med] 2009 Aug 24; Vol. 7, pp. 42. Date of Electronic Publication: 2009 Aug 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

تفاصيل العنوان

×
  • 1-7 ل  7 نتائج ل ""Phase III as Topic""